Corporate ActionSep 17, 2026, 07:16 PM
Electra Therapeutics Files to Increase Stock Offering by 1.9M Shares
AI Summary
Electra Therapeutics, Inc. has filed a Form S-1 registration statement to increase the number of shares of common stock offered in its public sale. The company is registering an additional 1,916,667 shares, including 250,000 shares subject to the underwriters' option to purchase additional shares. This filing is made under Rule 462(b) and is intended to increase the aggregate offering size by no more than 20% compared to the earlier registration statement, which was declared effective on September 17, 2026.
Key Highlights
- Electra Therapeutics, Inc. is filing a registration statement to increase the number of shares of common stock offered.
- The company is registering an additional 1,916,667 shares of common stock.
- This filing is made under Rule 462(b) of the Securities Act of 1933.
- The additional shares represent no more than 20% of the maximum aggregate offering price from the earlier registration statement.
- The earlier registration statement (File No. 333-298617) was declared effective on September 17, 2026.
Price Impact